ASCIA Guidelines – Standardised infusion rates for intravenous immunoglobulin replacement therapy

These Guidelines are currently under review and have therefore been removed from the ASCIA website in May 2024. 

In the meantime, we suggest that clinicians follow the information from the suppliers of each IVIg product or refer to the RCH VIC IVIg Guideline.

Content updated November 2024